Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on oncology.
Quote | Delcath Systems Inc. (OTCMKTS:DCTH)
Last: | $12.75 |
---|---|
Change Percent: | 0.0% |
Open: | $12.75 |
Close: | $12.75 |
High: | $12.75 |
Low: | $12.75 |
Volume: | 312 |
Last Trade Date Time: | 04/28/2020 04:45:48 am |
News | Delcath Systems Inc. (OTCMKTS:DCTH)
Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PR Newswire NEW YORK , April 4, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary ...
2024-03-27 09:15:03 ET Canaccord Genuity analyst issues BUY recommendation for DCTH on March 27, 2024 08:09AM ET. The previous analyst recommendation was Buy. DCTH was trading at $4.61 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curre...
Message Board Posts | Delcath Systems Inc. (OTCMKTS:DCTH)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $DCTH 23% v573K c6.00 f10,046M H6.27 ML4.24 | znewcar1 | investorshangout | 03/27/2023 9:48:00 PM |
znewcar1: DCTH 23% v1,3M c15.10 f6,2M (note F was 9M in 2019-0614) this has been RS to death. | znewcar1 | investorshangout | 04/05/2021 9:02:16 PM |
znewcar1: DCTH 19% v170K c.12374 f9,M R.15 S.1186 | znewcar1 | investorshangout | 06/14/2019 8:52:15 PM |
znewcar1: DCTH 126% v3,9M c.215 f9,0M H .217 EOD push | znewcar1 | investorshangout | 04/16/2019 8:03:08 PM |
znewcar1: 28.60% v576,177 c.4901 f9,007,952 H.6 interesting | znewcar1 | investorshangout | 11/22/2018 4:44:36 AM |
News, Short Squeeze, Breakout and More Instantly...
Delcath Systems Inc. Company Name:
DCTH Stock Symbol:
OTCMKTS Market:
Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PR Newswire NEW YORK , April 4, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary ...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
2024-03-27 09:15:03 ET Canaccord Genuity analyst issues BUY recommendation for DCTH on March 27, 2024 08:09AM ET. The previous analyst recommendation was Buy. DCTH was trading at $4.61 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curre...